Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
6.52
0.00 (0.00%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Evolus Market Cap
Evolus has a market cap or net worth of $421.75 million as of September 17, 2025. Its market cap has decreased by -57.77% in one year.
Market Cap
421.75M
Enterprise Value
514.92M
1-Year Change
-57.77%
Ranking
Category
Stock Price
$6.52
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $421.75M, an increase of 55.44%. That is a compound annual growth rate of 5.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 421.75M | -39.67% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | 113.40M | -72.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |